Your browser doesn't support javascript.
loading
RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins.
Jeter, Martha L; Ly, Linda V; Fortenberry, Yolanda M; Whinna, Herbert C; White, Rebekah R; Rusconi, Christopher P; Sullenger, Bruce A; Church, Frank C.
  • Jeter ML; Department of Pathology and Laboratory Medicine, Carolina Cardiovascular Biology Center, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC 27599-7035, USA.
FEBS Lett ; 568(1-3): 10-4, 2004 Jun 18.
Article en En | MEDLINE | ID: mdl-15196911
ABSTRACT
We studied the RNA aptamer Toggle-25/thrombin interaction during inhibition by antithrombin (AT), heparin cofactor II (HCII) and protein C inhibitor (PCI). Thrombin inhibition was reduced 3-fold by Toggle-25 for AT and HCII, but it was slightly enhanced for PCI. In the presence of glycosaminoglycans, AT and PCI had significantly reduced thrombin inhibition with Toggle-25, but it was only reduced 3-fold for HCII. This suggested that the primary effect of aptamer binding was through the heparin-binding site of thrombin, anion-binding exosite-2 (exosite-2). We localized the Toggle-25 binding site to Arg 98, Glu 169, Lys 174, Asp 175, Arg 245, and Lys 248 of exosite-2. We conclude that a RNA aptamer to thrombin exosite-2 might provide an effective clinical reagent to control heparin's anticoagulant action.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: ARN / Heparina / Trombina / Cofactor II de Heparina / Antitrombinas / Inhibidor de Proteína C Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2004 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: ARN / Heparina / Trombina / Cofactor II de Heparina / Antitrombinas / Inhibidor de Proteína C Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2004 Tipo del documento: Article